Safety concerns remain for developing replicating vectors based on the pathogen human immunodeficiency virus type 1.
Ben Berkhout
Advertisement
Articles by Ben Berkhout
Advertisement
Latest Updated Articles
Evolution of Live-Attenuated HIV VaccinesPublished: January 2nd 2011 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
2
Report - Digital Transformation in Biopharma: The Gap Between Hype and Implementation
3
Reducing CAR-T Manufacturing Times and Cost: Q&A with Trenchant’s Jon Ellis
4
BioPharm Weekly News Roundup—Week of Oct. 6, 2025
5
